v3.22.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:      
Net income $ 230,141 $ 118,503 $ 626,698
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 472,000 336,000 252,000
Amortization of deferred commissions 294,000 218,000 168,000
Amortization of debt discount and issuance costs 7,000 24,000 33,000
Stock-based compensation 1,131,000 870,000 662,000
Deferred income taxes (34,000) (24,000) (576,000)
Repayments of convertible senior notes attributable to debt discount (15,000) (82,000) 0
Loss on extinguishment of 2022 Notes 3,000 47,000 0
Other 45,000 (2,000) (8,000)
Changes in operating assets and liabilities, net of effect of business combinations:      
Accounts receivable (401,000) (152,000) (260,000)
Deferred commissions (565,000) (365,000) (255,000)
Prepaid expenses and other assets (93,000) (55,000) (30,000)
Accounts payable 55,000 (34,000) 21,000
Deferred revenue 960,000 711,000 537,000
Accrued expenses and other liabilities 102,000 175,000 65,000
Net cash provided by operating activities 2,191,000 1,786,000 1,236,000
Cash flows from investing activities:      
Purchases of property and equipment (392,000) (419,000) (265,000)
Business combinations, net of cash acquired (785,000) (107,000) (7,000)
Purchases of intangibles (7,000) (13,000) (73,000)
Purchases of investments (2,485,000) (2,922,000) (1,596,000)
Purchases of strategic investments (71,000) (12,000) 0
Sales and maturities of investments 2,119,000 1,965,000 1,193,000
Other 14,000 1,000 23,000
Net cash used in investing activities (1,607,000) (1,507,000) (725,000)
Cash flows from financing activities:      
Net proceeds from borrowings on 2030 Notes 0 1,482,000 0
Repayments of convertible senior notes attributable to principal (61,000) (1,628,000) 0
Net proceeds from unwind of 2022 Note Hedge 0 1,106,000 0
Proceeds from employee stock plans 167,000 146,000 108,000
Taxes paid related to net share settlement of equity awards (612,000) (509,000) (410,000)
Net cash provided by (used in) financing activities (506,000) 597,000 (302,000)
Foreign currency effect on cash, cash equivalents and restricted cash (25,000) 25,000 0
Net increase in cash, cash equivalents and restricted cash 53,000 901,000 209,000
Cash, cash equivalents and restricted cash at beginning of period 1,679,000 778,000 569,000
Cash, cash equivalents and restricted cash at end of period 1,732,000 1,679,000 778,000
Cash, cash equivalents and restricted cash at end of period:      
Cash and cash equivalents 1,728,000 1,677,000 776,000
Current portion of restricted cash included in prepaid expenses and other current assets 4,000 2,000 2,000
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows 1,732,000 1,679,000 778,000
Supplemental disclosures of other cash flow information:      
Interest paid 41,000 0 0
Income taxes paid, net of refunds 36,000 39,000 20,000
Non-cash investing and financing activities:      
Settlement of 2022 Notes conversion feature 225,000 275,000 0
Benefit from exercise of 2022 Note Hedge 224,000 273,000 0
Property and equipment included in accounts payable and accrued expenses $ 63,000 $ 35,000 $ 57,000